Inside Innovation

Aptevo Therapeutics, a Seattle-based biotech company, has seen a 46% rise in stock price per share as a result of positive data from its ongoing

A new wearable device used to detect opioid overdoses is under development at the University of Washington. The device would be able to detect an

Anavasi Diagnostics, a Washington-based startup, has received a total of $20.9 million in funding from the U.S. National Institutes of Health and individual investors to

The Allen Institute has launched a new division focused on exploring how the brain learns, memorizes and executes other complex actions. Karel Svoboda will be

If you enjoy spending time outdoors, Seattle is one of the best places in the U.S. to live and work, according to a recent SmartAsset

Thanks to a $20 million donation from Paul G Allen, late co-founder of Microsoft, Swedish Medical Services will be launching a research center focused on

Last week Absci celebrated the opening of its new headquarters, complete with 77,400 square feet of office and lab space. Washington state Governor Jay Inslee

Mozart Therapeutics has secured $55 million to develop celiac disease therapies. The Seattle-based biotech startup will use these funds for preclinical studies of the company’s

To address ongoing Covid-19 infections in low-income countries, The Bill & Melinda Gates Foundation is donating $120 million to increase access to molnupiravir, an antiviral

While many companies across the U.S. shifted to remote work in 2020, Seattle became the top market for tech firms looking for large office spaces.

During Dr. Leslie Alexandre’s five years as CEO of Life Science Washington, the region’s life science industry has experienced a massive rise in IPOs and

Life Science Washington’s economic impact reports reveals a 23.5% rise in employment in the field from 2015-2019, reflecting tremendous growth in the region as a